Literature DB >> 20626043

Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?

Inge M C M de Kok1, Maaike A van der Aa, Marjolein van Ballegooijen, Sabine Siesling, Henrike E Karim-Kos, Folkert J van Kemenade, Jan Willem W Coebergh.   

Abstract

We explored trends in incidence and mortality of cervical cancer by age, stage and morphology, and linked the observed trends to screening activities. Data was retrieved from the Netherlands Cancer Registry during 1989-2007 (incidence) and Statistics Netherlands during 1970-2007 (mortality). Trends were evaluated by calculating the estimated annual percentage change (EAPC). Joinpoint regression analysis was used to detect changes in trends. Cervical intraepithelial neoplasia (CIN) detection rates were calculated by data from "the nationwide network and registry of histo- and cytopathology" during 1990-2006. Total age-adjusted incidence rate (European standardized rate (ESR)) was 7.9 per 100,000 woman years in 2007. During 1989-1998, incidence rates decreased with an EAPC of -1.3% (95% confidence interval (CI) -2.2 to -0.3), during 1998-2001 with -6.7% (95% CI: -16.4 to 4.1), and increased during 2001-2007 with 2.3% (95% CI: 0.4 to 4.2). Total mortality ESR was 1.9 per 100,000 woman years in 2007. Mortality rates decreased during 1970-1994 annually with -4.1% (95% CI: -4.6% to -3.7%), and with -2.6% (95% CI: -3.8% to -1.5%) during 1994-2007. The observed trend in total incidence is similar to the trend in squamous cell carcinomas in age group 35-54 years, suggesting that the observed trends are likely to be associated to changes in the screening program. This is supported by the trend in CINIII detection rates. In conclusion, incidence and mortality overall decreased and leveled off. On top of that there was an extra decrease that was compensated by a following recent increase in incidence, probably resulting from reorganization of the Dutch screening program.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 20626043     DOI: 10.1002/ijc.25553

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Recommendations on screening for cervical cancer.

Authors:  James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

2.  Prospective detection of cervical dysplasia with scanning angle-resolved low coherence interferometry.

Authors:  Wesley Y Kendall; Derek Ho; Kengyeh Chu; Michael Zinaman; Daryl Wieland; Kandis Moragne; Adam Wax
Journal:  Biomed Opt Express       Date:  2020-08-20       Impact factor: 3.732

3.  Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005.

Authors:  Rasmus Hoffmann; Iris Plug; Martin McKee; Bernadette Khoshaba; Ragnar Westerling; Caspar Looman; Gregoire Rey; Eric Jougla; Katrin Lang; Kersti Pärna; Johan P Mackenbach
Journal:  Int J Public Health       Date:  2013-08-29       Impact factor: 3.380

4.  A population-based evaluation of cervical screening in the United States: 2008-2011.

Authors:  Jack Cuzick; Orrin Myers; William C Hunt; Michael Robertson; Nancy E Joste; Philip E Castle; Vicki B Benard; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-03       Impact factor: 4.254

5.  Efficacy of Raman Spectroscopy in the Diagnosis of Uterine Cervical Neoplasms: A Meta-Analysis.

Authors:  Zhuo-Wei Shen; Li-Jie Zhang; Zhuo-Yi Shen; Zhi-Feng Zhang; Fan Xu; Xiao Zhang; Rui Li; Zhen Xiao
Journal:  Front Med (Lausanne)       Date:  2022-05-06

6.  A sandwich SERS immunoassay platform based on a single-layer Au-Ag nanobox array substrate for simultaneous detection of SCCA and survivin in serum of patients with cervical lesions.

Authors:  Yifan Liu; Menglin Ran; Yue Sun; Yongxin Fan; Jinghan Wang; Xiaowei Cao; Dan Lu
Journal:  RSC Adv       Date:  2021-11-16       Impact factor: 4.036

7.  The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.

Authors:  Marta Cervantes-Amat; Gonzalo López-Abente; Nuria Aragonés; Marina Pollán; Roberto Pastor-Barriuso; Beatriz Pérez-Gómez
Journal:  BMC Cancer       Date:  2015-04-15       Impact factor: 4.430

8.  Cytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping.

Authors:  Yoon Yang Jung; Ji Hae Nahm; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2016-11-08

9.  Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.

Authors:  Judith van der Horst; Albert G Siebers; Johan Bulten; Leon F Massuger; Inge McM de Kok
Journal:  Cancer Med       Date:  2017-01-19       Impact factor: 4.452

10.  Distribution of Carcinogenic Human Papillomavirus Genotypes and Association to Cervical Lesions among Women in Fez (Morocco).

Authors:  Tiatou Souho; Hinde El Fatemi; Safae Karim; Karima El Rhazi; Chahrazed Bouchikhi; Abdelaziz Banani; Moulay Abdelilah Melhouf; Mohamed Benlemlih; Bahia Bennani
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.